Top 7 Hot Stocks: This OMC PSU can give 45% return; Tata firm downgraded; diagnostics stock double upgraded
Top 7 Hot Stocks: Share market opened on a lower note in the first trading session of the week on Monday. While BSE tanked over 750 points, Nifty 50 slipped to below 21,850 points amid broad-based sell-off. While the market is going through a volatile phase, brokerages such as Goldman Sachs, Jefferies, Yes Securities, Motilal Oswal, and CLSA have picked stocks such as Tata Motors, Cipla, Bharat Petroleum, Hero MotoCorp, Bank of Baroda, Dr Lal Pathlabs, and more. Know brokerage calls and target prices for these stocks.
Photos: Unsplash/Pixabay
Yes Securities on Tata Motors (CMP: Rs 1047)
The brokerage has given an 'add' call on the stock with a target price of Rs 1,192, a 14% upside.
Goldman Sachs on Cipla Ltd (CMP: 1340)
Goldman Sachs has maintained a 'sell' call on the firm, raising its target to Rs 1,265 from Rs 1,250.
Yes Securities on Bharat Petroleum (CMP: Rs 619)
Yes Securities has given a 'buy' call on the firm with a target price of Rs 900, which signifies a potential return of 45%.
Jefferies on Cipla Ltd (CMP: 1340)
Jefferies has maintained a 'hold' call on the firm, raising its target to Rs 1,400 from Rs 1,250.
Yes Securities on Hindustan Petroleum (CMP: 501)
The brokerage has given a 'buy' call on the OMC PSU with a target price of Rs 700. It has a potential return of 38%.
Motilal Oswal on Canara Bank (CMP: 558)
Motilal Oswal has given a 'buy' call on the lender with a target price of Rs 650, a 17% upside.
Motilal Oswal on Hero MotoCorp (CMP: 4,624)
The brokerage has given a 'buy' call on the automaker with a target price of Rs 5,320, a 15% upside.
CLSA on Eicher Motors Ltd (CMP 4657)
CLSA has downgraded the automaker to 'sell' from 'underperform', raising the target raised to Rs 4,157 from Rs 3,955.
Yes Securities on Bank of Baroda (CMP: 255)
The brokerage has given a 'buy' call on the lender with a target prie of Rs 350, a potential return of 37%.
CLSA on Dr Lal PathLabs (CMP: 2348)
CLSA has double upgraded the diagnostics stock to 'outperform' from 'underperform', raising its target to Rs 2,590 from Rs 2,510.
Goldman Sachs on Dr Lal PathLabs (CMP: 2348)
Goldman Sachs has maintained a 'sell' call on the diagnostics firm, cutting its target to Rs 2,150 from Rs 2,200.
Citi on Mahanagar Gas (CMP:1301)
Citi has double upgraded to 'buy' from 'neutral', raising its target to Rs 1,550 from Rs 1,405.